Cite
HARVARD Citation
Tamjid, B. et al. (2017). Efficacy and toxicity of PACEBOM chemotherapy in relapsed/refractory aggressive lymphoma in the rituximab era. Asia-Pacific journal of clinical oncology. 13 (3), pp. 226-233. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Tamjid, B. et al. (2017). Efficacy and toxicity of PACEBOM chemotherapy in relapsed/refractory aggressive lymphoma in the rituximab era. Asia-Pacific journal of clinical oncology. 13 (3), pp. 226-233. [Online].